Post Herpetic Neuralgia Treatment Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Post Herpetic Neuralgia Treatment Market is expected to grow at the highest CAGR of 5% during the forecast period 2022-2028.

Post-herpetic neuralgia (PHN) is neuropathic pain that is usually caused by an injury. In many cases, peripheral nerve damage is caused by a recurrence of a virus called varicella zoster. This virus causes shingles or shingles. Neuralgia usually occurs in an area with a single sensory nerve. Post-herpetic neuralgia can last for about 85 days. A person can also suffer from a variety of other conditions along with PHN. For example, itching, abnormal sensations, pain from soft touch, hyperalgesia, etc.

Market Segments

By Type:

• Anticonvulsants
• Skin Patch
• Other

By Application:

• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies

Key Players

• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.
• Mylan N.V.
• Endo Pharmaceuticals Inc.
• Daiichi Sankyo
• Acorda Therapeutics
• Purdue Pharma L.P
• Teikoku Pharma USA, Inc.
• Janssen Pharmaceuticals, Inc.

Scope of the Report

The research study analyzes the global Post Herpetic Neuralgia Treatment industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Post Herpetic Neuralgia Treatment Market Report

1. What was the Post Herpetic Neuralgia Treatment Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Post Herpetic Neuralgia Treatment Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Post Herpetic Neuralgia Treatment Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.